Clinical Trial Update: Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 1/Phase 2 study of topical methylene blue photodynamic therapy (MB-PDT) for burn wound infections. The trial status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns
• Wound Infection

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: University of Oklahoma | Conditions: Burns, Wound Infection | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING